Large-scale testing (Phase 3)Ended earlyNCT02697136
What this trial is testing
CER-001 Therapy as a Novel Approach to Treat Genetic Orphan Diseases
Who this might be right for
Familial Hypoalphalipoproteinemia
Cerenis Therapeutics, SA 30
Showing 10 of 10 results